These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30743017)

  • 21. Exploration of comorbid obsessive-compulsive disorder in patients with bipolar disorder: The clinic-based prevalence rate, symptoms nature and clinical correlates.
    Jeon S; Baek JH; Yang SY; Choi Y; Ahn SW; Ha K; Hong KS
    J Affect Disord; 2018 Jan; 225():227-233. PubMed ID: 28841485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obsessive-compulsive Disorder with Comorbid Bipolar Disorders: Clinical Features and Treatment Implications.
    Mucci F; Toni C; Favaretto E; Vannucchi G; Marazziti D; Perugi G
    Curr Med Chem; 2018; 25(41):5722-5730. PubMed ID: 29119914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bipolar disorder comorbidity in patients with obsessive-compulsive disorder: Prevalence and predictors.
    Domingues-Castro MS; Torresan RC; Shavitt RG; Fontenelle LF; Ferrão YA; Rosário MC; Torres AR
    J Affect Disord; 2019 Sep; 256():324-330. PubMed ID: 31201983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electroconvulsive therapy for manic state with mixed and psychotic features in a teenager with bipolar disorder and comorbid episodic obsessive-compulsive disorder: a case report.
    Rask O; Suneson K; Holmström E; Bäckström B; Johansson BA
    J Med Case Rep; 2017 Dec; 11(1):345. PubMed ID: 29228982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G; Toni C; Frare F; Travierso MC; Hantouche E; Akiskal HS
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of the obsessive-compulsive and bipolar disorders comorbidity: pharmacodynamic and pharmacokinetic evaluation.
    Marazziti D; Mucci F; Avella MT; Dell'Oste V; Baroni S; Dell'Osso L
    Expert Opin Drug Metab Toxicol; 2019 Aug; 15(8):619-631. PubMed ID: 31271537
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical management of comorbid bipolar disorder and obsessive-compulsive disorder: A case series.
    Amerio A; Tonna M; Odone A
    Acta Biomed; 2018 Nov; 89(4):581-584. PubMed ID: 30657129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological augmentation of serotonin reuptake inhibitors in patients with obsessive-compulsive disorder: A network meta-analysis.
    Maiti R; Mishra A; Srinivasan A; Mishra BR
    Acta Psychiatr Scand; 2023 Jul; 148(1):19-31. PubMed ID: 37177823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of obsessive-compulsive disorder comorbidity on the sociodemographic and clinical features of patients with bipolar disorder.
    Koyuncu A; Tükel R; Ozyildirim I; Meteris H; Yazici O
    Compr Psychiatry; 2010; 51(3):293-7. PubMed ID: 20399339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.
    Pessina E; Albert U; Bogetto F; Maina G
    Int Clin Psychopharmacol; 2009 Sep; 24(5):265-9. PubMed ID: 19629012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparative Study of Aripiprazole, Olanzapine, and L-Methylfolate Augmentation in Treatment Resistant Obsessive-Compulsive Disorder.
    Dar SA; Wani RA; Haq I
    Psychiatr Q; 2021 Dec; 92(4):1413-1424. PubMed ID: 33830427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Romeo VM; Santoro V; Settineri S; Spina E; Zoccali RA
    J Clin Psychopharmacol; 2011 Apr; 31(2):174-9. PubMed ID: 21346614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial).
    Sayyah M; Sayyah M; Boostani H; Ghaffari SM; Hoseini A
    Depress Anxiety; 2012 Oct; 29(10):850-4. PubMed ID: 22933237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study.
    Ak M; Bulut SD; Bozkurt A; Ozsahin A
    Adv Ther; 2011 Apr; 28(4):341-8. PubMed ID: 21437763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbid obsessive-compulsive disorder with bipolar disorder: A distinct form?
    Ozdemiroglu F; Sevincok L; Sen G; Mersin S; Kocabas O; Karakus K; Vahapoglu F
    Psychiatry Res; 2015 Dec; 230(3):800-5. PubMed ID: 26561371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aripiprazole augmentation in treating comorbid bipolar disorder and obsessive-compulsive disorder.
    Amerio A; Odone A
    Gen Psychiatr; 2018; 31(3):e100007. PubMed ID: 30582130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbid obsessive compulsive disorder in patients with bipolar-I disorder.
    Shashidhara M; Sushma BR; Viswanath B; Math SB; Janardhan Reddy YC
    J Affect Disord; 2015 Mar; 174():367-71. PubMed ID: 25545603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.
    Saxena S; Wang D; Bystritsky A; Baxter LR
    J Clin Psychiatry; 1996 Jul; 57(7):303-6. PubMed ID: 8666572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive-Compulsive Disorder in Childhood.
    Akyol Ardic U; Ercan ES; Kutlu A; Yuce D; Ipci M; Inci SB
    Child Psychiatry Hum Dev; 2017 Oct; 48(5):699-704. PubMed ID: 27812841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.